The global medical AI market size was estimated at USD 42.62 billion in 2025 and is projected to grow from USD 56.20 billion in 2026 to USD 1.05 trillion by 2036, at a CAGR of 34.0% from 2026 to 2036. The North America Medical AI market held the largest share of 44.01% of the global market in 2025.
Increasing demand for minimally invasive surgery and clinical precision, growing adoption of real-time health tracking and personalized wellness solutions, increasing demand for minimally invasive surgery and clinical precision, and rising demand for cost-effective drug development are significant factors contributing to market growth.
This product will be delivered within 1-3 business days.
Increasing demand for minimally invasive surgery and clinical precision, growing adoption of real-time health tracking and personalized wellness solutions, increasing demand for minimally invasive surgery and clinical precision, and rising demand for cost-effective drug development are significant factors contributing to market growth.
Global Medical AI Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2036. For this study, the analyst has segmented the medical AI market report based on, end use, application, patient journey, and region:Application Outlook (Revenue, USD Million, 2021-2036)
- Medical Imaging Diagnostics AI
- Digital Pathology AI
- Genomic Diagnostics AI
- Bio-signal Diagnostics/Physiologic Signal AI
- Multimodal Diagnostics AI
- Clinical & Treatment Support
- Robot-Assisted Surgery
- Virtual Assistants
- Administrative Workflow Assistants
- Clinical Trials
- Fraud Detection
- Cybersecurity
- Dosage Error Reduction
- Precision medicine
- Drug discovery & development
- Lifestyle management & remote patient monitoring
- Wearables
- Patient engagement
- Others
End Use Outlook (Revenue, USD Million, 2021-2036)
- Healthcare Providers
- Hospitals
- Physician groups/clinics
- Ambulatory / specialty care centers
- Others (Dialysis centers, Cardiac diagnostic centers, etc.)
- Life Sciences
- Pharmaceutical companies
- Biotechnology companies
- CROs / clinical research organizations
- Patient
- Payer
- Others (Academic medical centers, Research institutes, etc.)
Patient Journey Outlook (Revenue, USD Million, 2021-2036)
- Prevention/Wellness
- Diagnostics
- Treatment / Intervention
- Post-care / Management
Regional Outlook (Revenue, USD Million, 2021-2036)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Kuwait
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definition
1.1.1.1. Application Segment
1.1.1.2. End Use Segment
1.2. Regional Scope
1.2.1. Estimates And Forecast Timeline
1.3. Objectives
1.3.1. Objective - 1
1.3.2. Objective - 2
1.3.3. Objective - 3
1.4. Research Methodology
1.5. Information Procurement
1.6. Market-specific Research Models
1.6.1. Consensus-based Estimates & Forecasting
1.6.2. Model 1: Commodity Flow Analysis
1.6.3. Model 2: Parent Market Analysis
1.6.4. Model 3: Country-level Multivariate Analysis Assumptions
1.6.5. Model 4: Segment-level Multivariate Analysis Assumptions
1.6.5.1. Medical AI Market CAGR Calculation
1.6.5.2. Variables Used For Market Analysis
1.6.5.3. Regional Analysis Matrix
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.1.1. Segment Definition
1.1.1.1. Application Segment
1.1.1.2. End Use Segment
1.2. Regional Scope
1.2.1. Estimates And Forecast Timeline
1.3. Objectives
1.3.1. Objective - 1
1.3.2. Objective - 2
1.3.3. Objective - 3
1.4. Research Methodology
1.5. Information Procurement
1.6. Market-specific Research Models
1.6.1. Consensus-based Estimates & Forecasting
1.6.2. Model 1: Commodity Flow Analysis
1.6.3. Model 2: Parent Market Analysis
1.6.4. Model 3: Country-level Multivariate Analysis Assumptions
1.6.5. Model 4: Segment-level Multivariate Analysis Assumptions
1.6.5.1. Medical AI Market CAGR Calculation
1.6.5.2. Variables Used For Market Analysis
1.6.5.3. Regional Analysis Matrix
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Application Segment Outlook - Part 1
2.3. Application Segment Outlook - Part 2
2.4. End Use And Patient Journey Segment Outlook
2.5. Competitive Landscape
2.2. Application Segment Outlook - Part 1
2.3. Application Segment Outlook - Part 2
2.4. End Use And Patient Journey Segment Outlook
2.5. Competitive Landscape
Chapter 3. Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Growing Adoption Of Real-time Health Tracking And Personalized Wellness Solutions
3.1.1.2. Rising Prevalence Of Cancer And Increasing Demand For Early Detection And Classification Of Cancer
3.1.1.2.1. Case Study 1
3.1.1.3. Increasing Demand For Minimally Invasive Surgery And Clinical Precision
3.1.1.4. Rising Demand For Cost-effective Drug Development
3.1.1.5. Growing Focus On Precision Medicine And Targeted Drug Development
3.1.1.5.1. Case Study 2
3.1.1.5.2. Case Study 3
3.1.1.5.3. Targeted Drug Development
3.1.1.6. Increasing Clinical Trials In Drug Repurposing
3.1.1.7. Growing Focus On Remote Patient Monitoring
3.1.2. Market Restraint Analysis
3.1.2.1. Cybersecurity And Privacy Concerns
3.1.2.2. Highly Regulated Industry
3.1.2.3. Limited Measurement Accuracy And Insufficient Clinical Validation
3.1.3. Market Opportunity Analysis
3.1.3.1. Opportunities In Digital Pathology AI Market
3.1.3.1.1. Emergence Of Quantitative Continuous Scoring (QCS) In Digital Pathology
3.1.3.2. Opportunities In AI In Drug Discovery Market
3.1.3.2.1. Quantum Simulation As An Emerging Technology in AI-Enabled Drug Discovery
3.1.3.2.1.1. Use Case Analysis: Kvantify Transforms Quantum Simulations For Drug Discovery With Gefion Supercomputer
3.1.3.2.2. New AI-based Repurposing Approaches
3.1.3.2.3. Disease- And Population-level Opportunities
3.1.3.3. Opportunities In Wearable AI Market
3.1.3.3.1. Gesture Recognition And Contactless Interaction
3.1.4. Market Challenges Analysis
3.1.4.1. Interoperability And Ecosystem Integration
3.1.4.2. High Implementation And Procurement Costs
3.2. Recent Developments In The AI In Drug Discovery Market
3.3. Recent Developments In The AI In Medical Imaging Market
3.4. Technological Overview
3.4.1. Technological Trends In AI In Drug Discovery
3.4.1.1. Advanced Algorithm Integration, Machine Learning, And Data Analytics In Drug Discovery
3.4.2. Technological Trends In Digital Pathology/Computational Pathology AI
3.5. Case Study Insights: AI In Drug Discovery
3.5.1. Case Study 1: AI-driven Molecular Intelligence For Accelerated Drug Discovery
3.5.2. Case Study 2: Syneos Health Accelerates Clinical Trials With Azure OpenAI Service
3.5.3. Case Study 3: Novo Nordisk Transforms Clinical Study Reports With Generative AI
3.5.4. Case Study 4: Accelerating Drug Ranking With Wipro Limited’s AI System
3.5.5. Case Study 5: Deepdrug Framework For Alzheimer’s Disease
3.6. Case Study Insights: Computational Pathology
3.6.1. Case Study 1: AI-enhanced Detection Of High-risk Prostate Cancer Features With Aiforia Prostate Cancer Suite
3.6.2. Case Study 2: Building Tools For Machine Learning And Artificial Intelligence In Computational Pathology
3.7. Case Study Insights: AI In Medical Imaging
3.7.1. Case Study 1: Enhancing Echocardiography Workflow And Ergonomics With GE Healthcare's Vivid AI Ultrasound System
3.7.2. Case Study 2: Accelerating ECG Diagnosis And Patient Care At Cardioparc With Cardiomatics AI-powered Analysis
3.8. Case Study Insights: AI In Administrative Workflow
3.8.1. Case Study 1: Transforming Front Desk Efficiency With Conversational AI In A Small Outpatient Clinic
3.9. Business Environment Analysis Tools
3.9.1. Porter’s Five Forces Analysis
3.9.2. Pestel Analysis
3.1.1. Market Driver Analysis
3.1.1.1. Growing Adoption Of Real-time Health Tracking And Personalized Wellness Solutions
3.1.1.2. Rising Prevalence Of Cancer And Increasing Demand For Early Detection And Classification Of Cancer
3.1.1.2.1. Case Study 1
3.1.1.3. Increasing Demand For Minimally Invasive Surgery And Clinical Precision
3.1.1.4. Rising Demand For Cost-effective Drug Development
3.1.1.5. Growing Focus On Precision Medicine And Targeted Drug Development
3.1.1.5.1. Case Study 2
3.1.1.5.2. Case Study 3
3.1.1.5.3. Targeted Drug Development
3.1.1.6. Increasing Clinical Trials In Drug Repurposing
3.1.1.7. Growing Focus On Remote Patient Monitoring
3.1.2. Market Restraint Analysis
3.1.2.1. Cybersecurity And Privacy Concerns
3.1.2.2. Highly Regulated Industry
3.1.2.3. Limited Measurement Accuracy And Insufficient Clinical Validation
3.1.3. Market Opportunity Analysis
3.1.3.1. Opportunities In Digital Pathology AI Market
3.1.3.1.1. Emergence Of Quantitative Continuous Scoring (QCS) In Digital Pathology
3.1.3.2. Opportunities In AI In Drug Discovery Market
3.1.3.2.1. Quantum Simulation As An Emerging Technology in AI-Enabled Drug Discovery
3.1.3.2.1.1. Use Case Analysis: Kvantify Transforms Quantum Simulations For Drug Discovery With Gefion Supercomputer
3.1.3.2.2. New AI-based Repurposing Approaches
3.1.3.2.3. Disease- And Population-level Opportunities
3.1.3.3. Opportunities In Wearable AI Market
3.1.3.3.1. Gesture Recognition And Contactless Interaction
3.1.4. Market Challenges Analysis
3.1.4.1. Interoperability And Ecosystem Integration
3.1.4.2. High Implementation And Procurement Costs
3.2. Recent Developments In The AI In Drug Discovery Market
3.3. Recent Developments In The AI In Medical Imaging Market
3.4. Technological Overview
3.4.1. Technological Trends In AI In Drug Discovery
3.4.1.1. Advanced Algorithm Integration, Machine Learning, And Data Analytics In Drug Discovery
3.4.2. Technological Trends In Digital Pathology/Computational Pathology AI
3.5. Case Study Insights: AI In Drug Discovery
3.5.1. Case Study 1: AI-driven Molecular Intelligence For Accelerated Drug Discovery
3.5.2. Case Study 2: Syneos Health Accelerates Clinical Trials With Azure OpenAI Service
3.5.3. Case Study 3: Novo Nordisk Transforms Clinical Study Reports With Generative AI
3.5.4. Case Study 4: Accelerating Drug Ranking With Wipro Limited’s AI System
3.5.5. Case Study 5: Deepdrug Framework For Alzheimer’s Disease
3.6. Case Study Insights: Computational Pathology
3.6.1. Case Study 1: AI-enhanced Detection Of High-risk Prostate Cancer Features With Aiforia Prostate Cancer Suite
3.6.2. Case Study 2: Building Tools For Machine Learning And Artificial Intelligence In Computational Pathology
3.7. Case Study Insights: AI In Medical Imaging
3.7.1. Case Study 1: Enhancing Echocardiography Workflow And Ergonomics With GE Healthcare's Vivid AI Ultrasound System
3.7.2. Case Study 2: Accelerating ECG Diagnosis And Patient Care At Cardioparc With Cardiomatics AI-powered Analysis
3.8. Case Study Insights: AI In Administrative Workflow
3.8.1. Case Study 1: Transforming Front Desk Efficiency With Conversational AI In A Small Outpatient Clinic
3.9. Business Environment Analysis Tools
3.9.1. Porter’s Five Forces Analysis
3.9.2. Pestel Analysis
Chapter 4. Medical AI Market: Application Estimates & Trend Analysis
4.1. Medical AI Market: Application Segment Dashboard
4.2. Medical AI Market: Application Segment Dashboard
4.3. Medical AI Market: Application Analysis, 2025 & 2036
4.4. Medical AI Market: Application Analysis, 2025 & 2036
4.5. Medical AI Market, By Application, 2021 - 2036 (USD Billion)
4.6. Medical Imaging Diagnostics AI
4.6.1. Medical Imaging Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.7. Digital Pathology AI
4.7.1. Digital Pathology AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.8. Genomic Diagnostics AI
4.8.1. Genomic Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.9. Bio-signal Diagnostics/Physiologic Signal AI
4.9.1. Bio-signal Diagnostics/Physiologic Signal AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.10. Multimodal Diagnostics AI
4.10.1. Multimodal Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.11. Clinical & Treatment Support
4.11.1. Clinical & Treatment Support Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.12. Robot-assisted Surgery
4.12.1. Robot-assisted Surgery Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.13. Virtual Assistants
4.13.1. Virtual Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.14. Administrative Workflow Assistants
4.14.1. Administrative Workflow Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.15. Clinical Trials
4.15.1. Clinical Trials Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.16. Fraud Detection
4.16.1. Fraud Detection Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.17. Cybersecurity
4.17.1. Cybersecurity Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.18. Dosage Error Reduction
4.18.1. Dosage Error Reduction Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.19. Precision Medicine
4.19.1. Precision Medicine Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.20. Drug Discovery & Development
4.20.1. Drug Discovery & Development Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.21. Lifestyle Management & Remote Patient Monitoring
4.21.1. Lifestyle Management & Remote Patient Monitoring Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.22. Wearable AI
4.22.1. Wearable AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.23. Patient
4.23.1. Patient Engagement Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.24. Others
4.24.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.2. Medical AI Market: Application Segment Dashboard
4.3. Medical AI Market: Application Analysis, 2025 & 2036
4.4. Medical AI Market: Application Analysis, 2025 & 2036
4.5. Medical AI Market, By Application, 2021 - 2036 (USD Billion)
4.6. Medical Imaging Diagnostics AI
4.6.1. Medical Imaging Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.7. Digital Pathology AI
4.7.1. Digital Pathology AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.8. Genomic Diagnostics AI
4.8.1. Genomic Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.9. Bio-signal Diagnostics/Physiologic Signal AI
4.9.1. Bio-signal Diagnostics/Physiologic Signal AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.10. Multimodal Diagnostics AI
4.10.1. Multimodal Diagnostics AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.11. Clinical & Treatment Support
4.11.1. Clinical & Treatment Support Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.12. Robot-assisted Surgery
4.12.1. Robot-assisted Surgery Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.13. Virtual Assistants
4.13.1. Virtual Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.14. Administrative Workflow Assistants
4.14.1. Administrative Workflow Assistants Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.15. Clinical Trials
4.15.1. Clinical Trials Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.16. Fraud Detection
4.16.1. Fraud Detection Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.17. Cybersecurity
4.17.1. Cybersecurity Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.18. Dosage Error Reduction
4.18.1. Dosage Error Reduction Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.19. Precision Medicine
4.19.1. Precision Medicine Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.20. Drug Discovery & Development
4.20.1. Drug Discovery & Development Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.21. Lifestyle Management & Remote Patient Monitoring
4.21.1. Lifestyle Management & Remote Patient Monitoring Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.22. Wearable AI
4.22.1. Wearable AI Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.23. Patient
4.23.1. Patient Engagement Market Estimates And Forecasts, 2021 - 2036 (USD Million)
4.24. Others
4.24.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
Chapter 5. Medical AI Market: End Use Estimates & Trend Analysis
5.1. Medical AI Market: End Use Segment Dashboard
5.2. Medical AI Market: End Use Analysis, 2025 & 2036
5.3. Medical AI Market, By End Use, 2021 - 2036 (USD Billion)
5.4. By End Use
5.4.1. Healthcare Providers
5.4.1.1. Hospitals
5.4.1.1.1. Hospitals Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.2. Physician Groups/Clinics
5.4.1.2.1. Physician Groups/Clinics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.3. Ambulatory / Specialty Care Centers
5.4.1.3.1. Ambulatory / Specialty Care Centers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.4. Others
5.4.1.4.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2. Life Sciences
5.4.2.1. Pharmaceutical Companies
5.4.2.1.1. Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2.2. Biotechnology Companies
5.4.2.2.1. Biotechnology Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2.3. Cros / Clinical Research Organizations
5.4.2.3.1. Cros / Clinical Research Organizations Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.3. Patient
5.4.3.1. Patient Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.4. Payers
5.4.4.1. Payers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.5. Others
5.4.5.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.2. Medical AI Market: End Use Analysis, 2025 & 2036
5.3. Medical AI Market, By End Use, 2021 - 2036 (USD Billion)
5.4. By End Use
5.4.1. Healthcare Providers
5.4.1.1. Hospitals
5.4.1.1.1. Hospitals Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.2. Physician Groups/Clinics
5.4.1.2.1. Physician Groups/Clinics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.3. Ambulatory / Specialty Care Centers
5.4.1.3.1. Ambulatory / Specialty Care Centers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.1.4. Others
5.4.1.4.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2. Life Sciences
5.4.2.1. Pharmaceutical Companies
5.4.2.1.1. Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2.2. Biotechnology Companies
5.4.2.2.1. Biotechnology Companies Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.2.3. Cros / Clinical Research Organizations
5.4.2.3.1. Cros / Clinical Research Organizations Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.3. Patient
5.4.3.1. Patient Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.4. Payers
5.4.4.1. Payers Market Estimates And Forecasts, 2021 - 2036 (USD Million)
5.4.5. Others
5.4.5.1. Others Market Estimates And Forecasts, 2021 - 2036 (USD Million)
Chapter 6. Medical AI Market: Patient Journey Estimates & Trend Analysis
6.1. Medical AI Market: Patient Journey Segment Dashboard
6.2. Medical AI Market: Patient Journey Analysis, 2025 & 2036
6.3. Medical AI Market, By Patient Journey, 2021 - 2036 (USD Billion)
6.4. By Patient Journey
6.4.1. Prevention/Wellness
6.4.1.1. Prevention/Wellness Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.2. Diagnostics
6.4.2.1. Diagnostics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.3. Treatment / Intervention
6.4.3.1. Treatment / Intervention Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.4. Post-care / Management
6.4.4.1. Post-care / Management Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.2. Medical AI Market: Patient Journey Analysis, 2025 & 2036
6.3. Medical AI Market, By Patient Journey, 2021 - 2036 (USD Billion)
6.4. By Patient Journey
6.4.1. Prevention/Wellness
6.4.1.1. Prevention/Wellness Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.2. Diagnostics
6.4.2.1. Diagnostics Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.3. Treatment / Intervention
6.4.3.1. Treatment / Intervention Market Estimates And Forecasts, 2021 - 2036 (USD Million)
6.4.4. Post-care / Management
6.4.4.1. Post-care / Management Market Estimates And Forecasts, 2021 - 2036 (USD Million)
Chapter 7. Medical AI Market: Regional Analysis
7.1. Regional Outlook
7.2. North America
7.2.1. North America Medical AI Market, 2021 - 2036 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory Framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Medical AI Market, 2021 - 2036 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Medical AI Market, 2021 - 2036 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory Framework
7.2.4.3. Competitive Scenario
7.2.4.4. Mexico Medical AI Market, 2021 - 2036 (USD Million)
7.3. Europe
7.3.1. Europe Medical AI Market, 2021 - 2036 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory Framework
7.3.2.3. Competitive Scenario
7.3.2.4. UK Medical AI Market, 2021 - 2036 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory Framework
7.3.3.3. Competitive Scenario
7.3.3.4. Germany Medical AI Market, 2021 - 2036 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory Framework
7.3.4.3. Competitive Scenario
7.3.4.4. France Medical AI Market, 2021 - 2036 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory Framework
7.3.5.3. Competitive Scenario
7.3.5.4. Italy Medical AI Market, 2021 - 2036 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory Framework
7.3.6.3. Competitive Scenario
7.3.6.4. Spain Medical AI Market, 2021 - 2036 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory Framework
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark Medical AI Market, 2021 - 2036 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory Framework
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden Medical AI Market, 2021 - 2036 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory Framework
7.3.9.3. Competitive Scenario
7.3.9.4. Norway Medical AI Market, 2021 - 2036 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Medical AI Market, 2021 - 2036 (USD Million)
7.4.2. China
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Scenario
7.4.2.4. China Medical AI Market, 2021 - 2036 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Medical AI Market, 2021 - 2036 (USD Million).
7.4.4. South Korea
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Scenario
7.4.4.4. South Korea Medical AI Market, 2021 - 2036 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory Framework
7.4.5.3. Competitive Scenario
7.4.5.4. India Medical AI Market, 2021 - 2036 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory Framework
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Medical AI Market, 2021 - 2036 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory Framework
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Medical AI Market, 2021 - 2036 (USD Million)
7.5. Latin America
7.5.1. Latin America Medical AI Market, 2021 - 2036 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil Medical AI Market, 2021 - 2036 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Scenario
7.5.3.4. Argentina Medical AI Market, 2021 - 2036 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Medical AI Market, 2021 - 2036 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa Medical AI Market, 2021 - 2036 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia Medical AI Market, 2021 - 2036 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Scenario
7.6.4.4. UAE Medical AI Market, 2021 - 2036 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait Medical AI Market, 2021 - 2036 (USD Million)
7.2. North America
7.2.1. North America Medical AI Market, 2021 - 2036 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory Framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. Medical AI Market, 2021 - 2036 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory Framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada Medical AI Market, 2021 - 2036 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory Framework
7.2.4.3. Competitive Scenario
7.2.4.4. Mexico Medical AI Market, 2021 - 2036 (USD Million)
7.3. Europe
7.3.1. Europe Medical AI Market, 2021 - 2036 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory Framework
7.3.2.3. Competitive Scenario
7.3.2.4. UK Medical AI Market, 2021 - 2036 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory Framework
7.3.3.3. Competitive Scenario
7.3.3.4. Germany Medical AI Market, 2021 - 2036 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory Framework
7.3.4.3. Competitive Scenario
7.3.4.4. France Medical AI Market, 2021 - 2036 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory Framework
7.3.5.3. Competitive Scenario
7.3.5.4. Italy Medical AI Market, 2021 - 2036 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory Framework
7.3.6.3. Competitive Scenario
7.3.6.4. Spain Medical AI Market, 2021 - 2036 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory Framework
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark Medical AI Market, 2021 - 2036 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory Framework
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden Medical AI Market, 2021 - 2036 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory Framework
7.3.9.3. Competitive Scenario
7.3.9.4. Norway Medical AI Market, 2021 - 2036 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Medical AI Market, 2021 - 2036 (USD Million)
7.4.2. China
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Scenario
7.4.2.4. China Medical AI Market, 2021 - 2036 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Medical AI Market, 2021 - 2036 (USD Million).
7.4.4. South Korea
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Scenario
7.4.4.4. South Korea Medical AI Market, 2021 - 2036 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory Framework
7.4.5.3. Competitive Scenario
7.4.5.4. India Medical AI Market, 2021 - 2036 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory Framework
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Medical AI Market, 2021 - 2036 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory Framework
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Medical AI Market, 2021 - 2036 (USD Million)
7.5. Latin America
7.5.1. Latin America Medical AI Market, 2021 - 2036 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil Medical AI Market, 2021 - 2036 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Scenario
7.5.3.4. Argentina Medical AI Market, 2021 - 2036 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Medical AI Market, 2021 - 2036 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa Medical AI Market, 2021 - 2036 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia Medical AI Market, 2021 - 2036 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Scenario
7.6.4.4. UAE Medical AI Market, 2021 - 2036 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait Medical AI Market, 2021 - 2036 (USD Million)
Chapter 8. Medical AI Market: Competitive Landscape
8.1. Medical Imaging Diagnostics
8.1.1. Participants’ Overview
8.1.1.1. Aidoc
8.1.1.2. Lunit INC
8.1.1.3. Behold.ai
8.1.1.4. Digital Diagnostics INC.
8.1.1.5. Tempus
8.1.1.6. Viz.ai, INC.
8.1.1.7. Us2.ai
8.1.1.8. Rad AI
8.1.1.9. Gleamer
8.1.1.10. Enlitic
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Company/Competition Categorization
8.1.5. Company Market Position Analysis, 2025
8.1.6. Company Market Share Analysis By Medical Imaging Diagnostics, 2025 (%)
8.1.7. Strategy Mapping
8.1.7.1. New Product Launch
8.1.7.2. Partnerships And Collaborations
8.1.7.3. Regional Expansion
8.1.7.4. Merger & Acquisition
8.1.7.5. Others
8.2. Digital Pathology
8.2.1. Participants’ Overview
8.2.1.1. Proscia INC.
8.2.1.2. Aignostics, INC.
8.2.1.3. Aiforia
8.2.1.4. Dedalus S.p.a
8.2.1.5. Gestalt
8.2.1.6. Paige AI
8.2.1.7. Path AI
8.2.1.8. Ibex Medical Analytics
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Company/Competition Categorization
8.2.5. Company Market Position Analysis, 2025
8.2.6. Company Market Share Analysis By Digital Pathology, 2025 (%)
8.2.7. Strategy Mapping
8.2.7.1. New Product Launch
8.2.7.2. Partnerships And Collaborations
8.2.7.3. Regional Expansion
8.2.7.4. Others
8.3. Genomic Diagnostics
8.3.1. Participants’ Overview
8.3.1.1. Caris Life Sciences
8.3.1.2. Tempus
8.3.1.3. Sophia Genetics
8.3.1.4. Genedx
8.3.1.5. Fabric Genomics
8.3.1.6. Genomenon
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Company/Competition Categorization
8.3.5. Company Market Position Analysis, 2025
8.3.6. Company Market Share Analysis By Genomic Diagnostics, 2025 (%)
8.3.7. Strategy Mapping
8.3.7.1. Product Launch
8.3.7.2. Partnerships And Collaborations
8.3.7.3. Product Expansion
8.3.7.4. Merger & Acquisition
8.4. Bio-signal Diagnostics
8.4.1. Participants’ Overview
8.4.1.1. Irhythm Technologies, INC.
8.4.1.2. Beacon Biosignals
8.4.1.3. Eko Health
8.4.1.4. Anumana
8.4.1.5. Cardiomatics
8.4.1.6. Withings Health
8.4.1.7. Medicalgorithmics.com
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Company/Competition Categorization
8.4.5. Company Market Position Analysis, 2025
8.4.6. Company Market Share Analysis By Bio-signal Diagnostics, 2025 (%)
8.4.7. Strategy Mapping
8.4.7.1. Product Launch
8.4.7.2. Partnerships And Collaborations
8.4.7.3. Merger & Acquisition
8.5. Multimodal Diagnostics
8.5.1. Participants’ Overview
8.5.1.1. Tempus
8.5.1.2. Viz.ai, INC.
8.5.1.3. Aidoc
8.5.1.4. Rapidai
8.5.1.5. Annalise.ai
8.5.1.6. Qure.ai
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Company/Competition Categorization
8.5.5. Company Market Position Analysis, 2025
8.5.6. Company Market Share Analysis By Multimodal Diagnostics, 2025 (%)
8.5.7. Strategy Mapping
8.5.7.1. Product Launch
8.5.7.2. Partnerships And Collaborations
8.5.7.3. Others
8.6. Clinical & Treatment Support
8.6.1. Participants’ Overview
8.6.1.1. Openevidence
8.6.1.2. Epic Systems Corporation
8.6.1.3. Regard
8.6.1.4. Ambience Healthcare
8.6.1.5. Glass Health
8.6.1.6. Wolters Kluwer
8.6.1.7. Corti
8.6.1.8. Nuance Communications
8.6.1.9. Navina AI
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Company/Competition Categorization
8.6.5. Company Market Position Analysis, 2025
8.6.6. Company Market Share Analysis By Clinical & Treatment Support, 2025 (%)
8.6.7. Strategy Mapping
8.6.7.1. Product Launch
8.6.7.2. Partnerships And Collaborations
8.6.7.3. Others
8.7. Drug Discovery & Development
8.7.1. Participants’ Overview
8.7.1.1. Bostongene Corporation
8.7.1.2. Benevolentai
8.7.1.3. Innophore
8.7.1.4. Bioxcel Therapeutics INC.
8.7.1.5. Owkin, INC
8.7.1.6. Insilico Medicine
8.7.1.7. Healx
8.7.1.8. IBM
8.7.1.9. Google (DeepMind)
8.7.1.10. Biosymetrics, INC.
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Company/Competition Categorization
8.7.5. Company Market Position Analysis, 2025
8.7.6. Company Market Share Analysis By Drug Discovery & Development, 2025 (%)
8.7.7. Strategy Mapping
8.7.7.1. Product/Service Launch
8.7.7.2. Partnerships And Collaborations
8.7.7.3. Regional Expansion
8.7.7.4. Merger & Acquisition
8.7.7.5. Others
8.8. Robot-assisted Surgery
8.8.1. Participants’ Overview
8.8.1.1. Intuitive Surgical
8.8.1.2. Stryker
8.8.1.3. Medtronic
8.8.1.4. Johnson & Johnson Medtech
8.8.1.5. Zimmer Biomet
8.8.1.6. Activ Surgical
8.8.1.7. Andromeda Surgical, INC.
8.8.1.8. Algosurg
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Company/Competition Categorization
8.8.5. Company Market Position Analysis, 2025
8.8.6. Company Market Share Analysis By Robot-assisted Surgery, 2025 (%)
8.8.7. Strategy Mapping
8.8.7.1. New Product Launch
8.8.7.2. Partnerships And Collaborations
8.8.7.3. Regulatory Approval
8.8.7.4. Regional Expansion
8.8.7.5. Merger & Acquisition
8.8.7.6. Others
8.9. Administrative Workflow Assistants
8.9.1. Participants’ Overview
8.9.1.1. Waystar
8.9.1.2. Abridge
8.9.1.3. Notable Health
8.9.1.4. Ambience Healthcare
8.9.1.5. R1 Rcm
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Company/Competition Categorization
8.9.5. Company Market Position Analysis, 2025
8.9.6. Company Market Share Analysis By Administrative Workflow Assistants, 2025 (%)
8.9.7. Strategy Mapping
8.9.7.1. Product/Service Launch
8.9.7.2. Partnerships And Collaborations
8.9.7.3. Merger & Acquisition
8.10. Connected Medical Devices
8.10.1. Participants’ Overview
8.10.1.1. Medtronic
8.10.1.2. Abbott
8.10.1.3. Dexcom
8.10.1.4. Irhythm Technologies
8.10.1.5. GE Healthcare
8.10.1.6. Siemens Healthineers
8.10.1.7. Koninklijke Philips N.v.
8.10.1.8. Validic, INC.
8.10.1.9. Biointellisense
8.10.1.10. Healthsnap, INC.
8.10.1.11. Roche
8.10.1.12. Idoven
8.10.1.13. Datos
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Company/Competition Categorization
8.10.5. Company Market Position Analysis, 2025
8.10.6. Strategy Mapping
8.10.6.1. Product Launch
8.10.6.2. Partnerships And Collaborations
8.10.6.3. Product Expansion
8.11. Clinical Trials
8.11.1. Participants’ Overview
8.11.1.1. Iqvia INC
8.11.1.2. Dassault Systèmes (Medidata)
8.11.1.3. Insilico Medicine
8.11.1.4. Tempus (Deep6.ai)
8.11.1.5. NVIDIA Corporation
8.11.1.6. Unlearn.ai, INC.
8.11.1.7. Saama
8.11.1.8. Antidote Technologies, INC.
8.11.1.9. Phesi
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Company/Competition Categorization
8.11.5. Company Market Position Analysis, 2025
8.11.6. Company Market Share Analysis By Clinical Trials, 2025 (%)
8.11.7. Strategy Mapping
8.11.7.1. Product Launch
8.11.7.2. Partnerships And Collaborations
8.11.7.3. Merger & Acquisition
8.12. Fraud Detection
8.12.1. Participants’ Overview
8.12.1.1. Codoxo
8.12.1.2. Experian Information Solutions, INC.
8.12.1.3. H2o.ai
8.12.1.4. Optum, INC. (Unitedhealth Group)
8.12.1.5. General Dynamics Information Technology, INC.
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Company/Competition Categorization
8.12.5. Company Market Position Analysis, 2025
8.12.6. Company Market Share Analysis By Fraud Detection, 2025 (%)
8.12.7. Strategy Mapping
8.12.7.1. Product Launch
8.12.7.2. Partnerships And Collaborations
8.12.7.3. Product Expansion
8.12.7.4. Merger & Acquisition
8.13. Cybersecurity
8.13.1 Participants’ Overview
8.13.1.1. CrowdStrike
8.13.1.2. Palo Alto Networks
8.13.1.3. Asimily
8.13.1.4. Arctic Wolf
8.13.1.5. Claroty
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Company/Competition Categorization
8.13.5. Company Market Position Analysis, 2025
8.13.6. Company Market Share Analysis By Cybersecurity, 2025 (%)
8.13.7. Strategy Mapping
8.13.7.1. Product Launch
8.13.7.2. Merger & Acquisition
8.14. Dosage Error Reduction
8.14.1. Participants’ Overview
8.14.1.1. Mvision AI INC.
8.14.1.2. Dosemerx
8.14.1.3. Merative
8.14.1.4. Medaware
8.14.1.5. Aicure
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Company/Competition Categorization
8.14.5. Company Market Position Analysis, 2025
8.14.6. Company Market Share Analysis By Dosage Error Reduction, 2025 (%)
8.14.7. Strategy Mapping
8.14.7.1. Regulatory Approval
8.14.7.2. Partnerships And Collaborations
8.15. Precision Medicine
8.15.1. Participants’ Overview
8.15.1.1. Bioxcel Therapeutics INC.
8.15.1.2. Sanofi
8.15.1.3. NVIDIA Corporation
8.15.1.4. Alphabet INC. (Google)
8.15.1.5. IBM
8.15.1.6. Microsoft
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Company/Competition Categorization
8.15.5. Company Market Position Analysis, 2025
8.15.6. Company Market Share Analysis By Precision Medicine, 2025 (%)
8.15.7. Strategy Mapping
8.15.7.1. Partnerships And Collaborations
8.15.7.2. Product Expansion
8.16. Wearables
8.16.1. Participant’s Overview
8.16.1.1. Samsung Electronics Co., Ltd.
8.16.1.2. Meta
8.16.1.3. Fitbit, INC.
8.16.1.4. Garmin LTD.
8.16.1.5. Google, INC. (Alphabet)
8.16.1.6. Huawei Technologies Co., Ltd.
8.16.1.7. Xiaomi
8.16.1.8. Apple, INC.
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Company/Competition Categorization
8.16.5. Company Market Position Analysis, 2025
8.16.6. Company Market Share Analysis By Wearables, 2025 (%)
8.16.7. Strategy Mapping
8.16.7.1. New Product Launch
8.16.7.2. Mergers And Acquisitions
8.16.7.3. Collaborations & Partnerships
8.16.7.4. Regional Expansion
8.16.7.5. Other Strategies
8.17. Patient Engagement
8.17.1. Participants’ Overview
8.17.1.1. Medadvisor Solutions
8.17.1.2. Innovaccer, INC.
8.17.1.3. Enlivenhealth (A Subdivision Of Omnicell, INC.)
8.17.1.4. Empirx Health, LLC.
8.17.1.5. IBM
8.17.1.6. Oracle
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Company/Competition Categorization
8.17.5. Company Market Position Analysis, 2025
8.17.6. Company Market Share Analysis By Patient Engagement, 2025 (%)
8.17.7. Strategy Mapping
8.17.7.1. Product Launch
8.17.7.2. Partnerships And Collaborations
8.17.7.3. Merger & Acquisition
8.1.1. Participants’ Overview
8.1.1.1. Aidoc
8.1.1.2. Lunit INC
8.1.1.3. Behold.ai
8.1.1.4. Digital Diagnostics INC.
8.1.1.5. Tempus
8.1.1.6. Viz.ai, INC.
8.1.1.7. Us2.ai
8.1.1.8. Rad AI
8.1.1.9. Gleamer
8.1.1.10. Enlitic
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Company/Competition Categorization
8.1.5. Company Market Position Analysis, 2025
8.1.6. Company Market Share Analysis By Medical Imaging Diagnostics, 2025 (%)
8.1.7. Strategy Mapping
8.1.7.1. New Product Launch
8.1.7.2. Partnerships And Collaborations
8.1.7.3. Regional Expansion
8.1.7.4. Merger & Acquisition
8.1.7.5. Others
8.2. Digital Pathology
8.2.1. Participants’ Overview
8.2.1.1. Proscia INC.
8.2.1.2. Aignostics, INC.
8.2.1.3. Aiforia
8.2.1.4. Dedalus S.p.a
8.2.1.5. Gestalt
8.2.1.6. Paige AI
8.2.1.7. Path AI
8.2.1.8. Ibex Medical Analytics
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Company/Competition Categorization
8.2.5. Company Market Position Analysis, 2025
8.2.6. Company Market Share Analysis By Digital Pathology, 2025 (%)
8.2.7. Strategy Mapping
8.2.7.1. New Product Launch
8.2.7.2. Partnerships And Collaborations
8.2.7.3. Regional Expansion
8.2.7.4. Others
8.3. Genomic Diagnostics
8.3.1. Participants’ Overview
8.3.1.1. Caris Life Sciences
8.3.1.2. Tempus
8.3.1.3. Sophia Genetics
8.3.1.4. Genedx
8.3.1.5. Fabric Genomics
8.3.1.6. Genomenon
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Company/Competition Categorization
8.3.5. Company Market Position Analysis, 2025
8.3.6. Company Market Share Analysis By Genomic Diagnostics, 2025 (%)
8.3.7. Strategy Mapping
8.3.7.1. Product Launch
8.3.7.2. Partnerships And Collaborations
8.3.7.3. Product Expansion
8.3.7.4. Merger & Acquisition
8.4. Bio-signal Diagnostics
8.4.1. Participants’ Overview
8.4.1.1. Irhythm Technologies, INC.
8.4.1.2. Beacon Biosignals
8.4.1.3. Eko Health
8.4.1.4. Anumana
8.4.1.5. Cardiomatics
8.4.1.6. Withings Health
8.4.1.7. Medicalgorithmics.com
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Company/Competition Categorization
8.4.5. Company Market Position Analysis, 2025
8.4.6. Company Market Share Analysis By Bio-signal Diagnostics, 2025 (%)
8.4.7. Strategy Mapping
8.4.7.1. Product Launch
8.4.7.2. Partnerships And Collaborations
8.4.7.3. Merger & Acquisition
8.5. Multimodal Diagnostics
8.5.1. Participants’ Overview
8.5.1.1. Tempus
8.5.1.2. Viz.ai, INC.
8.5.1.3. Aidoc
8.5.1.4. Rapidai
8.5.1.5. Annalise.ai
8.5.1.6. Qure.ai
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Company/Competition Categorization
8.5.5. Company Market Position Analysis, 2025
8.5.6. Company Market Share Analysis By Multimodal Diagnostics, 2025 (%)
8.5.7. Strategy Mapping
8.5.7.1. Product Launch
8.5.7.2. Partnerships And Collaborations
8.5.7.3. Others
8.6. Clinical & Treatment Support
8.6.1. Participants’ Overview
8.6.1.1. Openevidence
8.6.1.2. Epic Systems Corporation
8.6.1.3. Regard
8.6.1.4. Ambience Healthcare
8.6.1.5. Glass Health
8.6.1.6. Wolters Kluwer
8.6.1.7. Corti
8.6.1.8. Nuance Communications
8.6.1.9. Navina AI
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Company/Competition Categorization
8.6.5. Company Market Position Analysis, 2025
8.6.6. Company Market Share Analysis By Clinical & Treatment Support, 2025 (%)
8.6.7. Strategy Mapping
8.6.7.1. Product Launch
8.6.7.2. Partnerships And Collaborations
8.6.7.3. Others
8.7. Drug Discovery & Development
8.7.1. Participants’ Overview
8.7.1.1. Bostongene Corporation
8.7.1.2. Benevolentai
8.7.1.3. Innophore
8.7.1.4. Bioxcel Therapeutics INC.
8.7.1.5. Owkin, INC
8.7.1.6. Insilico Medicine
8.7.1.7. Healx
8.7.1.8. IBM
8.7.1.9. Google (DeepMind)
8.7.1.10. Biosymetrics, INC.
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Company/Competition Categorization
8.7.5. Company Market Position Analysis, 2025
8.7.6. Company Market Share Analysis By Drug Discovery & Development, 2025 (%)
8.7.7. Strategy Mapping
8.7.7.1. Product/Service Launch
8.7.7.2. Partnerships And Collaborations
8.7.7.3. Regional Expansion
8.7.7.4. Merger & Acquisition
8.7.7.5. Others
8.8. Robot-assisted Surgery
8.8.1. Participants’ Overview
8.8.1.1. Intuitive Surgical
8.8.1.2. Stryker
8.8.1.3. Medtronic
8.8.1.4. Johnson & Johnson Medtech
8.8.1.5. Zimmer Biomet
8.8.1.6. Activ Surgical
8.8.1.7. Andromeda Surgical, INC.
8.8.1.8. Algosurg
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Company/Competition Categorization
8.8.5. Company Market Position Analysis, 2025
8.8.6. Company Market Share Analysis By Robot-assisted Surgery, 2025 (%)
8.8.7. Strategy Mapping
8.8.7.1. New Product Launch
8.8.7.2. Partnerships And Collaborations
8.8.7.3. Regulatory Approval
8.8.7.4. Regional Expansion
8.8.7.5. Merger & Acquisition
8.8.7.6. Others
8.9. Administrative Workflow Assistants
8.9.1. Participants’ Overview
8.9.1.1. Waystar
8.9.1.2. Abridge
8.9.1.3. Notable Health
8.9.1.4. Ambience Healthcare
8.9.1.5. R1 Rcm
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Company/Competition Categorization
8.9.5. Company Market Position Analysis, 2025
8.9.6. Company Market Share Analysis By Administrative Workflow Assistants, 2025 (%)
8.9.7. Strategy Mapping
8.9.7.1. Product/Service Launch
8.9.7.2. Partnerships And Collaborations
8.9.7.3. Merger & Acquisition
8.10. Connected Medical Devices
8.10.1. Participants’ Overview
8.10.1.1. Medtronic
8.10.1.2. Abbott
8.10.1.3. Dexcom
8.10.1.4. Irhythm Technologies
8.10.1.5. GE Healthcare
8.10.1.6. Siemens Healthineers
8.10.1.7. Koninklijke Philips N.v.
8.10.1.8. Validic, INC.
8.10.1.9. Biointellisense
8.10.1.10. Healthsnap, INC.
8.10.1.11. Roche
8.10.1.12. Idoven
8.10.1.13. Datos
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Company/Competition Categorization
8.10.5. Company Market Position Analysis, 2025
8.10.6. Strategy Mapping
8.10.6.1. Product Launch
8.10.6.2. Partnerships And Collaborations
8.10.6.3. Product Expansion
8.11. Clinical Trials
8.11.1. Participants’ Overview
8.11.1.1. Iqvia INC
8.11.1.2. Dassault Systèmes (Medidata)
8.11.1.3. Insilico Medicine
8.11.1.4. Tempus (Deep6.ai)
8.11.1.5. NVIDIA Corporation
8.11.1.6. Unlearn.ai, INC.
8.11.1.7. Saama
8.11.1.8. Antidote Technologies, INC.
8.11.1.9. Phesi
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Company/Competition Categorization
8.11.5. Company Market Position Analysis, 2025
8.11.6. Company Market Share Analysis By Clinical Trials, 2025 (%)
8.11.7. Strategy Mapping
8.11.7.1. Product Launch
8.11.7.2. Partnerships And Collaborations
8.11.7.3. Merger & Acquisition
8.12. Fraud Detection
8.12.1. Participants’ Overview
8.12.1.1. Codoxo
8.12.1.2. Experian Information Solutions, INC.
8.12.1.3. H2o.ai
8.12.1.4. Optum, INC. (Unitedhealth Group)
8.12.1.5. General Dynamics Information Technology, INC.
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Company/Competition Categorization
8.12.5. Company Market Position Analysis, 2025
8.12.6. Company Market Share Analysis By Fraud Detection, 2025 (%)
8.12.7. Strategy Mapping
8.12.7.1. Product Launch
8.12.7.2. Partnerships And Collaborations
8.12.7.3. Product Expansion
8.12.7.4. Merger & Acquisition
8.13. Cybersecurity
8.13.1 Participants’ Overview
8.13.1.1. CrowdStrike
8.13.1.2. Palo Alto Networks
8.13.1.3. Asimily
8.13.1.4. Arctic Wolf
8.13.1.5. Claroty
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Company/Competition Categorization
8.13.5. Company Market Position Analysis, 2025
8.13.6. Company Market Share Analysis By Cybersecurity, 2025 (%)
8.13.7. Strategy Mapping
8.13.7.1. Product Launch
8.13.7.2. Merger & Acquisition
8.14. Dosage Error Reduction
8.14.1. Participants’ Overview
8.14.1.1. Mvision AI INC.
8.14.1.2. Dosemerx
8.14.1.3. Merative
8.14.1.4. Medaware
8.14.1.5. Aicure
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Company/Competition Categorization
8.14.5. Company Market Position Analysis, 2025
8.14.6. Company Market Share Analysis By Dosage Error Reduction, 2025 (%)
8.14.7. Strategy Mapping
8.14.7.1. Regulatory Approval
8.14.7.2. Partnerships And Collaborations
8.15. Precision Medicine
8.15.1. Participants’ Overview
8.15.1.1. Bioxcel Therapeutics INC.
8.15.1.2. Sanofi
8.15.1.3. NVIDIA Corporation
8.15.1.4. Alphabet INC. (Google)
8.15.1.5. IBM
8.15.1.6. Microsoft
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Company/Competition Categorization
8.15.5. Company Market Position Analysis, 2025
8.15.6. Company Market Share Analysis By Precision Medicine, 2025 (%)
8.15.7. Strategy Mapping
8.15.7.1. Partnerships And Collaborations
8.15.7.2. Product Expansion
8.16. Wearables
8.16.1. Participant’s Overview
8.16.1.1. Samsung Electronics Co., Ltd.
8.16.1.2. Meta
8.16.1.3. Fitbit, INC.
8.16.1.4. Garmin LTD.
8.16.1.5. Google, INC. (Alphabet)
8.16.1.6. Huawei Technologies Co., Ltd.
8.16.1.7. Xiaomi
8.16.1.8. Apple, INC.
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Company/Competition Categorization
8.16.5. Company Market Position Analysis, 2025
8.16.6. Company Market Share Analysis By Wearables, 2025 (%)
8.16.7. Strategy Mapping
8.16.7.1. New Product Launch
8.16.7.2. Mergers And Acquisitions
8.16.7.3. Collaborations & Partnerships
8.16.7.4. Regional Expansion
8.16.7.5. Other Strategies
8.17. Patient Engagement
8.17.1. Participants’ Overview
8.17.1.1. Medadvisor Solutions
8.17.1.2. Innovaccer, INC.
8.17.1.3. Enlivenhealth (A Subdivision Of Omnicell, INC.)
8.17.1.4. Empirx Health, LLC.
8.17.1.5. IBM
8.17.1.6. Oracle
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Company/Competition Categorization
8.17.5. Company Market Position Analysis, 2025
8.17.6. Company Market Share Analysis By Patient Engagement, 2025 (%)
8.17.7. Strategy Mapping
8.17.7.1. Product Launch
8.17.7.2. Partnerships And Collaborations
8.17.7.3. Merger & Acquisition
List of Tables
Table 1 List of abbreviations
Table 2 Global Medical AI market, by region, 2021 - 2036 (USD Million)
Table 3 Global Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 4 Global Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 5 Global Medical AI market, by application, 2021 - 2036 (USD Million)
Table 6 North America Medical AI market, by country, 2021 - 2036 (USD Million)
Table 7 North America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 8 North America Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 9 North America Medical AI market, by application, 2021 - 2036 (USD Million)
Table 10 U.S. Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 11 U.S. Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 12 U.S. Medical AI market, by application, 2021 - 2036 (USD Million)
Table 13 Canada Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 14 Canada Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 15 Canada Medical AI market, by application, 2021 - 2036 (USD Million)
Table 16 Mexico Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 17 Mexico Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 18 Mexico Medical AI market, by application, 2021 - 2036 (USD Million)
Table 19 Europe Medical AI market, by country, 2021 - 2036 (USD Million)
Table 20 Europe Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 21 Europe Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 22 Europe Medical AI market, by application, 2021 - 2036 (USD Million)
Table 23 UK Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 24 UK Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 25 UK Medical AI market, by application, 2021 - 2036 (USD Million)
Table 26 Germany Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 27 Germany Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 28 Germany Medical AI market, by application, 2021 - 2036 (USD Million)
Table 29 France Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 30 France Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 31 France Medical AI market, by application, 2021 - 2036 (USD Million)
Table 32 Italy Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 33 Italy Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 34 Italy Medical AI market, by application, 2021 - 2036 (USD Million)
Table 35 Spain Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 36 Spain Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 37 Spain Medical AI market, by application, 2021 - 2036 (USD Million)
Table 38 Denmark Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 39 Denmark Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 40 Denmark Medical AI market, by application, 2021 - 2036 (USD Million)
Table 41 Sweden Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 42 Sweden Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 43 Sweden Medical AI market, by application, 2021 - 2036 (USD Million)
Table 44 Norway Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 45 Norway Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 46 Norway Medical AI market, by application, 2021 - 2036 (USD Million)
Table 47 Asia Pacific Medical AI market, by country, 2021 - 2036 (USD Million)
Table 48 Asia Pacific Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 49 Asia Pacific Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 50 Asia Pacific Medical AI market, by application, 2021 - 2036 (USD Million)
Table 51 China Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 52 China Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 53 China Medical AI market, by application, 2021 - 2036 (USD Million)
Table 54 Japan Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 55 Japan Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 56 Japan Medical AI market, by application, 2021 - 2036 (USD Million)
Table 57 India Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 58 India Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 59 India Medical AI market, by application, 2021 - 2036 (USD Million)
Table 60 South Korea Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 61 South Korea Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 62 South Korea Medical AI market, by application, 2021 - 2036 (USD Million)
Table 63 Australia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 64 Australia Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 65 Australia Medical AI market, by application, 2021 - 2036 (USD Million)
Table 66 Thailand Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 67 Thailand Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 68 Thailand Medical AI market, by application, 2021 - 2036 (USD Million)
Table 69 Latin America Medical AI market, by country, 2021 - 2036 (USD Million)
Table 70 Latin America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 71 Latin America Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 72 Latin America Medical AI market, by application, 2021 - 2036 (USD Million)
Table 73 Brazil Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 74 Brazil Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 75 Brazil Medical AI market, by application, 2021 - 2036 (USD Million)
Table 76 Argentina Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 77 Argentina Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 78 Argentina Medical AI market, by application, 2021 - 2036 (USD Million)
Table 79 Middle East & Africa Medical AI market, by country, 2021 - 2036 (USD Million)
Table 80 Middle East & Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 81 Middle East & Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 82 Middle East & Africa Medical AI market, by application, 2021 - 2036 (USD Million)
Table 83 South Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 84 South Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 85 South Africa Medical AI market, by application, 2021 - 2036 (USD Million)
Table 86 Saudi Arabia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 87 Saudi Arabia Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 88 Saudi Arabia Medical AI market, by application, 2021 - 2036 (USD Million)
Table 89 UAE Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 90 UAE Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 91 UAE Medical AI market, by application, 2021 - 2036 (USD Million)
Table 92 Kuwait Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 93 Kuwait Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 94 Kuwait Medical AI market, by application, 2021 - 2036 (USD Million)
Table 2 Global Medical AI market, by region, 2021 - 2036 (USD Million)
Table 3 Global Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 4 Global Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 5 Global Medical AI market, by application, 2021 - 2036 (USD Million)
Table 6 North America Medical AI market, by country, 2021 - 2036 (USD Million)
Table 7 North America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 8 North America Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 9 North America Medical AI market, by application, 2021 - 2036 (USD Million)
Table 10 U.S. Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 11 U.S. Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 12 U.S. Medical AI market, by application, 2021 - 2036 (USD Million)
Table 13 Canada Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 14 Canada Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 15 Canada Medical AI market, by application, 2021 - 2036 (USD Million)
Table 16 Mexico Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 17 Mexico Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 18 Mexico Medical AI market, by application, 2021 - 2036 (USD Million)
Table 19 Europe Medical AI market, by country, 2021 - 2036 (USD Million)
Table 20 Europe Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 21 Europe Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 22 Europe Medical AI market, by application, 2021 - 2036 (USD Million)
Table 23 UK Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 24 UK Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 25 UK Medical AI market, by application, 2021 - 2036 (USD Million)
Table 26 Germany Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 27 Germany Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 28 Germany Medical AI market, by application, 2021 - 2036 (USD Million)
Table 29 France Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 30 France Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 31 France Medical AI market, by application, 2021 - 2036 (USD Million)
Table 32 Italy Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 33 Italy Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 34 Italy Medical AI market, by application, 2021 - 2036 (USD Million)
Table 35 Spain Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 36 Spain Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 37 Spain Medical AI market, by application, 2021 - 2036 (USD Million)
Table 38 Denmark Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 39 Denmark Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 40 Denmark Medical AI market, by application, 2021 - 2036 (USD Million)
Table 41 Sweden Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 42 Sweden Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 43 Sweden Medical AI market, by application, 2021 - 2036 (USD Million)
Table 44 Norway Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 45 Norway Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 46 Norway Medical AI market, by application, 2021 - 2036 (USD Million)
Table 47 Asia Pacific Medical AI market, by country, 2021 - 2036 (USD Million)
Table 48 Asia Pacific Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 49 Asia Pacific Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 50 Asia Pacific Medical AI market, by application, 2021 - 2036 (USD Million)
Table 51 China Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 52 China Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 53 China Medical AI market, by application, 2021 - 2036 (USD Million)
Table 54 Japan Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 55 Japan Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 56 Japan Medical AI market, by application, 2021 - 2036 (USD Million)
Table 57 India Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 58 India Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 59 India Medical AI market, by application, 2021 - 2036 (USD Million)
Table 60 South Korea Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 61 South Korea Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 62 South Korea Medical AI market, by application, 2021 - 2036 (USD Million)
Table 63 Australia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 64 Australia Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 65 Australia Medical AI market, by application, 2021 - 2036 (USD Million)
Table 66 Thailand Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 67 Thailand Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 68 Thailand Medical AI market, by application, 2021 - 2036 (USD Million)
Table 69 Latin America Medical AI market, by country, 2021 - 2036 (USD Million)
Table 70 Latin America Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 71 Latin America Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 72 Latin America Medical AI market, by application, 2021 - 2036 (USD Million)
Table 73 Brazil Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 74 Brazil Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 75 Brazil Medical AI market, by application, 2021 - 2036 (USD Million)
Table 76 Argentina Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 77 Argentina Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 78 Argentina Medical AI market, by application, 2021 - 2036 (USD Million)
Table 79 Middle East & Africa Medical AI market, by country, 2021 - 2036 (USD Million)
Table 80 Middle East & Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 81 Middle East & Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 82 Middle East & Africa Medical AI market, by application, 2021 - 2036 (USD Million)
Table 83 South Africa Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 84 South Africa Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 85 South Africa Medical AI market, by application, 2021 - 2036 (USD Million)
Table 86 Saudi Arabia Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 87 Saudi Arabia Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 88 Saudi Arabia Medical AI market, by application, 2021 - 2036 (USD Million)
Table 89 UAE Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 90 UAE Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 91 UAE Medical AI market, by application, 2021 - 2036 (USD Million)
Table 92 Kuwait Medical AI market, by patient journey, 2021 - 2036 (USD Million)
Table 93 Kuwait Medical AI market, by end use, 2021 - 2036 (USD Million)
Table 94 Kuwait Medical AI market, by application, 2021 - 2036 (USD Million)
List of Figures
Fig. 1 Medical AI market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Commodity flow analysis
Fig. 5 Parent market analysis
Fig. 6 Market snapshot
Fig. 7 Application segment outlook - Part 1
Fig. 8 Application segment outlook - Part 2
Fig. 9 End use and patient journey segment outlook
Fig. 10 Competitive landscape
Fig. 11 Market dynamics
Fig. 12 Market driver relevance analysis
Fig. 13 Estimated new cancer cases in the U.S. in 2025
Fig. 14 Areas of interest most likely to benefit from AI in the next 10 years
Fig. 15 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Fig. 16 Approximate number of procedures performed on da Vinci surgical systems in the U.S. and outside the U.S. (OUS) for the periods presented. (‘000)
Fig. 17 Case study insights: Leveraging ai to develop more personalized cancer treatment strategies at the University of Oxford
Fig. 18 Key features of artificial intelligence in remote patient monitoring
Fig. 19 Strategic initiatives related to disease/indication
Fig. 20 Market restraint relevance analysis
Fig. 21 Few notable fundings in the AI in drug repurposing industry
Fig. 22 Recent AI launches and collaborations in digital and computational pathology by market players
Fig. 23 Benefits of AI integration in digital and computational pathology
Fig. 24 Case study 1: AI-driven molecular intelligence for accelerated drug discovery
Fig. 25 Case study 4: Accelerating drug ranking with Wipro Limited’s AI system
Fig. 26 Case study 5: Deep Drug framework for Alzheimer’s disease
Fig. 27 Case study 1: AI-powered prostate cancer diagnostics
Fig. 28 Case study 2: Enhancing echocardiography workflow and ergonomics with GE Healthcare's Vivid Ai Ultrasound System
Fig. 29 Case study 3: Accelerating ECG diagnosis and patient care at CardioParc with Cardiomatics AI-powered analysis
Fig. 30 Medical AI market: Porter’s five forces analysis
Fig. 31 Medical AI market: PESTEL analysis
Fig. 32 Medical AI market: Application outlook key takeaways (USD Billion)
Fig. 33 Medical AI market: Application outlook key takeaways (USD Billion)
Fig. 34 Medical AI market: Application movement analysis, 2025 & 2036
Fig. 35 Medical AI market: Application movement analysis, 2025 & 2036
Fig. 36 Medical imaging diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 37 Digital pathology AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 38 Genomic diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 39 Bio-signal diagnostics/physiologic signal AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 40 Case study insights: Multimodal craniocerebral diagnosis using 3D CT and image reports
Fig. 41 Multimodal diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 42 Clinical & treatment support market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 43 Robot-assisted surgery market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 44 Virtual assistants market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 45 Administrative workflow assistants market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 46 Clinical trials market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 47 Fraud detection market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 48 Cybersecurity market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 49 Dosage error reduction market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 50 Precision medicine market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 51 Drug discovery & development market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 52 Lifestyle management & remote patient monitoring market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 53 Wearable AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 54 Patient engagement market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 55 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 56 Medical AI market: End use outlook key takeaways (USD Billion)
Fig. 57 Medical AI market: End use movement analysis, 2025 & 2036
Fig. 58 Hospitals market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 59 Physician groups/clinics market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 60 Ambulatory / specialty care centers market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 61 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 62 Pharmaceutical companies market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 63 Biotechnology companies market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 64 CROs / clinical research organizations market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 65 Patient market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 66 Payers market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 67 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 68 Medical AI market: Patient journey outlook key takeaways (USD Billion)
Fig. 69 Medical AI market: Patient journey movement analysis, 2025 & 2036
Fig. 70 Prevention/wellness market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 71 Diagnostics market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 72 Treatment / intervention market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 73 Post-care / management market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 74 Medical AI market revenue, by region
Fig. 75 Global Medical AI market: Regional outlook and key takeaways
Fig. 76 Global Medical AI market: Regional movement analysis
Fig. 77 North America market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 78 U.S. key country dynamics
Fig. 79 U.S. market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 80 Canada key country dynamics
Fig. 81 Canada market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 82 Mexico key country dynamics
Fig. 83 Mexico market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 84 Europe market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 85 UK key country dynamics
Fig. 86 UK market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 87 Germany key country dynamics
Fig. 88 Germany market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 89 France key country dynamics
Fig. 90 France market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 91 Italy key country dynamics
Fig. 92 Italy market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 93 Spain key country dynamics
Fig. 94 Spain market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 95 Denmark key country dynamics
Fig. 96 Denmark market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 97 Sweden key country dynamics
Fig. 98 Sweden market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 99 Norway key country dynamics
Fig. 100 Norway market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 101 Asia Pacific market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 102 Japan key country dynamics
Fig. 103 Japan market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 104 China key country dynamics
Fig. 105 China market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 106 India key country dynamics
Fig. 107 India market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 108 Thailand key country dynamics
Fig. 109 Thailand market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 110 South Korea key country dynamics
Fig. 111 South Korea market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 112 Australia key country dynamics
Fig. 113 Australia market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 114 Latin America market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 115 Brazil key country dynamics
Fig. 116 Brazil market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 117 Argentina key country dynamics
Fig. 118 Argentina market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 119 Middle East and Africa market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 120 South Africa key country dynamics
Fig. 121 South Africa market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 122 Saudi Arabia key country dynamics
Fig. 123 Saudi Arabia market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 124 UAE key country dynamics
Fig. 125 UAE market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 126 Kuwait key country dynamics
Fig. 127 Kuwait market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 128 Company categorization
Fig. 129 Company market position analysis, 2025
Fig. 130 Company market share analysis, 2025
Fig. 131 Strategy mapping
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Commodity flow analysis
Fig. 5 Parent market analysis
Fig. 6 Market snapshot
Fig. 7 Application segment outlook - Part 1
Fig. 8 Application segment outlook - Part 2
Fig. 9 End use and patient journey segment outlook
Fig. 10 Competitive landscape
Fig. 11 Market dynamics
Fig. 12 Market driver relevance analysis
Fig. 13 Estimated new cancer cases in the U.S. in 2025
Fig. 14 Areas of interest most likely to benefit from AI in the next 10 years
Fig. 15 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Fig. 16 Approximate number of procedures performed on da Vinci surgical systems in the U.S. and outside the U.S. (OUS) for the periods presented. (‘000)
Fig. 17 Case study insights: Leveraging ai to develop more personalized cancer treatment strategies at the University of Oxford
Fig. 18 Key features of artificial intelligence in remote patient monitoring
Fig. 19 Strategic initiatives related to disease/indication
Fig. 20 Market restraint relevance analysis
Fig. 21 Few notable fundings in the AI in drug repurposing industry
Fig. 22 Recent AI launches and collaborations in digital and computational pathology by market players
Fig. 23 Benefits of AI integration in digital and computational pathology
Fig. 24 Case study 1: AI-driven molecular intelligence for accelerated drug discovery
Fig. 25 Case study 4: Accelerating drug ranking with Wipro Limited’s AI system
Fig. 26 Case study 5: Deep Drug framework for Alzheimer’s disease
Fig. 27 Case study 1: AI-powered prostate cancer diagnostics
Fig. 28 Case study 2: Enhancing echocardiography workflow and ergonomics with GE Healthcare's Vivid Ai Ultrasound System
Fig. 29 Case study 3: Accelerating ECG diagnosis and patient care at CardioParc with Cardiomatics AI-powered analysis
Fig. 30 Medical AI market: Porter’s five forces analysis
Fig. 31 Medical AI market: PESTEL analysis
Fig. 32 Medical AI market: Application outlook key takeaways (USD Billion)
Fig. 33 Medical AI market: Application outlook key takeaways (USD Billion)
Fig. 34 Medical AI market: Application movement analysis, 2025 & 2036
Fig. 35 Medical AI market: Application movement analysis, 2025 & 2036
Fig. 36 Medical imaging diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 37 Digital pathology AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 38 Genomic diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 39 Bio-signal diagnostics/physiologic signal AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 40 Case study insights: Multimodal craniocerebral diagnosis using 3D CT and image reports
Fig. 41 Multimodal diagnostics AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 42 Clinical & treatment support market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 43 Robot-assisted surgery market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 44 Virtual assistants market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 45 Administrative workflow assistants market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 46 Clinical trials market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 47 Fraud detection market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 48 Cybersecurity market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 49 Dosage error reduction market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 50 Precision medicine market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 51 Drug discovery & development market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 52 Lifestyle management & remote patient monitoring market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 53 Wearable AI market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 54 Patient engagement market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 55 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 56 Medical AI market: End use outlook key takeaways (USD Billion)
Fig. 57 Medical AI market: End use movement analysis, 2025 & 2036
Fig. 58 Hospitals market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 59 Physician groups/clinics market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 60 Ambulatory / specialty care centers market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 61 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 62 Pharmaceutical companies market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 63 Biotechnology companies market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 64 CROs / clinical research organizations market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 65 Patient market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 66 Payers market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 67 Others market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 68 Medical AI market: Patient journey outlook key takeaways (USD Billion)
Fig. 69 Medical AI market: Patient journey movement analysis, 2025 & 2036
Fig. 70 Prevention/wellness market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 71 Diagnostics market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 72 Treatment / intervention market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 73 Post-care / management market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 74 Medical AI market revenue, by region
Fig. 75 Global Medical AI market: Regional outlook and key takeaways
Fig. 76 Global Medical AI market: Regional movement analysis
Fig. 77 North America market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 78 U.S. key country dynamics
Fig. 79 U.S. market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 80 Canada key country dynamics
Fig. 81 Canada market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 82 Mexico key country dynamics
Fig. 83 Mexico market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 84 Europe market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 85 UK key country dynamics
Fig. 86 UK market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 87 Germany key country dynamics
Fig. 88 Germany market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 89 France key country dynamics
Fig. 90 France market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 91 Italy key country dynamics
Fig. 92 Italy market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 93 Spain key country dynamics
Fig. 94 Spain market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 95 Denmark key country dynamics
Fig. 96 Denmark market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 97 Sweden key country dynamics
Fig. 98 Sweden market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 99 Norway key country dynamics
Fig. 100 Norway market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 101 Asia Pacific market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 102 Japan key country dynamics
Fig. 103 Japan market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 104 China key country dynamics
Fig. 105 China market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 106 India key country dynamics
Fig. 107 India market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 108 Thailand key country dynamics
Fig. 109 Thailand market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 110 South Korea key country dynamics
Fig. 111 South Korea market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 112 Australia key country dynamics
Fig. 113 Australia market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 114 Latin America market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 115 Brazil key country dynamics
Fig. 116 Brazil market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 117 Argentina key country dynamics
Fig. 118 Argentina market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 119 Middle East and Africa market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 120 South Africa key country dynamics
Fig. 121 South Africa market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 122 Saudi Arabia key country dynamics
Fig. 123 Saudi Arabia market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 124 UAE key country dynamics
Fig. 125 UAE market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 126 Kuwait key country dynamics
Fig. 127 Kuwait market estimates and forecasts, 2021 - 2036 (USD Million)
Fig. 128 Company categorization
Fig. 129 Company market position analysis, 2025
Fig. 130 Company market share analysis, 2025
Fig. 131 Strategy mapping
Companies Mentioned
- Aidoc
- Tempus
- iRhythm Technologies
- Intuitive Surgical
- Lunit Inc.
- Viz.ai, Inc.
- Eko Health
- Stryker
- Proscia Inc.
- RapidAI
- Cardiomatics
- Medtronic
- SOPHiA Genetics
- Qure.ai
- Epic Systems Corporation
- Johnson & Johnson MedTech
- Caris Life Sciences
- Annalise.ai
- Ambience Healthcare
- Zimmer Biomet
- GeneDx
- OpenEvidence
- Nuance / Microsoft Dragon Copilot
- Activ Surgical
- Fabric Genomics
- Regard (Max)
- Waystar
- IQVIA Inc.
- BenevolentAI
- Glass Health
- Abridge
- Insilico Medicine
- Owkin, Inc.
- Wolters Kluwer (UpToDate ExpertAI)
- Codoxo
- NVIDIA Corporation
- Insilico Medicine
- Corti AI
- CrowdStrike
- Alphabet / Google (DeepMind)
- Samsung Electronics
- Apple Inc.
- Dexcom
- Abbott
- Fitbit (Google)
- Garmin Ltd.
- GE HealthCare
- Siemens Healthineers
- BioIntelliSense
- Innovaccer, Inc.
- Optum, Inc.
- Philips Healthcare
- MVision AI Inc.
- DoseMeRx
- MedAware
- IQVIA
- Unlearn.ai, Inc.
- Saama
- Deep6.ai
